Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders

Marie Ociskova,1,2 Jan Prasko,2 Dana Kamaradova,2 Ales Grambal,2 Petra Kasalova,2 Zuzana Sigmundova,2 Klara Latalova,2 Kristyna Vrbova2 1Department of Psychology, Faculty of Arts, 2Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc,...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Ociskova M, Prasko J, Kamaradova D, Grambal A, Kasalova P, Sigmundova Z, Latalova K, Vrbova K
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/1c9076f8df884d93a82979148a293db7
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:1c9076f8df884d93a82979148a293db7
record_format	dspace
spelling	oai:doaj.org-article:1c9076f8df884d93a82979148a293db72021-12-02T05:25:21ZCoping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders1178-2021https://doaj.org/article/1c9076f8df884d93a82979148a293db72015-05-01T00:00:00Zhttp://www.dovepress.com/coping-strategies-hope-and-treatment-efficacy-in-pharmacoresistant-inp-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Marie Ociskova,1,2 Jan Prasko,2 Dana Kamaradova,2 Ales Grambal,2 Petra Kasalova,2 Zuzana Sigmundova,2 Klara Latalova,2 Kristyna Vrbova2 1Department of Psychology, Faculty of Arts, 2Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc, Olomouc, Czech Republic Background: Approximately 30%–60% of patients with neurotic spectrum disorders remain symptomatic despite treatment. Identifying the predictors of good response to psychiatric and psychotherapeutic treatment may be useful for increasing treatment efficacy in neurotic patients. The objective of this study was to investigate the influence of hope, coping strategies, and dissociation on the treatment response of this group of patients.Methods: Pharmacoresistant patients, who underwent a 6-week psychotherapeutic program, were enrolled in the study. All patients completed the Clinical Global Impression (CGI) – both objective and subjective forms, Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI)-II at baseline and after 6 weeks. The COPE Inventory, the Adult Dispositional Hope Scale (ADHS), and the Dissociative Experiences Scale (DES) were completed at the start of the treatment.Results: Seventy-six patients completed the study. The mean scores for all scales measuring the severity of the disorders (BAI, BDI-II, subjective and objective CGI) significantly decreased during the treatment. Several subscores of the COPE Inventory, the overall score of ADHS, and the overall score of DES significantly correlated with the treatment outcome. Multiple regression was used to find out which factors were the most significant predictors of the therapeutic outcomes. The most important predictors of the treatment response were the overall levels of hope and dissociation.Conclusion: According to our results, a group of patients with a primary neurotic disorder, who prefer the use of maladaptive coping strategies, feel hopelessness, and have tendencies to dissociate, showed poor response to treatment. Keywords: neurotic spectrum disorders, treatment efficacy, dissociation, coping strategy, hopeOciskova MPrasko JKamaradova DGrambal AKasalova PSigmundova ZLatalova KVrbova KDove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 1191-1201 (2015)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Ociskova M Prasko J Kamaradova D Grambal A Kasalova P Sigmundova Z Latalova K Vrbova K Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
description	Marie Ociskova,1,2 Jan Prasko,2 Dana Kamaradova,2 Ales Grambal,2 Petra Kasalova,2 Zuzana Sigmundova,2 Klara Latalova,2 Kristyna Vrbova2 1Department of Psychology, Faculty of Arts, 2Department of Psychiatry, Faculty of Medicine and Dentistry, Palacky University Olomouc, University Hospital Olomouc, Olomouc, Czech Republic Background: Approximately 30%–60% of patients with neurotic spectrum disorders remain symptomatic despite treatment. Identifying the predictors of good response to psychiatric and psychotherapeutic treatment may be useful for increasing treatment efficacy in neurotic patients. The objective of this study was to investigate the influence of hope, coping strategies, and dissociation on the treatment response of this group of patients.Methods: Pharmacoresistant patients, who underwent a 6-week psychotherapeutic program, were enrolled in the study. All patients completed the Clinical Global Impression (CGI) – both objective and subjective forms, Beck Anxiety Inventory (BAI), and Beck Depression Inventory (BDI)-II at baseline and after 6 weeks. The COPE Inventory, the Adult Dispositional Hope Scale (ADHS), and the Dissociative Experiences Scale (DES) were completed at the start of the treatment.Results: Seventy-six patients completed the study. The mean scores for all scales measuring the severity of the disorders (BAI, BDI-II, subjective and objective CGI) significantly decreased during the treatment. Several subscores of the COPE Inventory, the overall score of ADHS, and the overall score of DES significantly correlated with the treatment outcome. Multiple regression was used to find out which factors were the most significant predictors of the therapeutic outcomes. The most important predictors of the treatment response were the overall levels of hope and dissociation.Conclusion: According to our results, a group of patients with a primary neurotic disorder, who prefer the use of maladaptive coping strategies, feel hopelessness, and have tendencies to dissociate, showed poor response to treatment. Keywords: neurotic spectrum disorders, treatment efficacy, dissociation, coping strategy, hope
format	article
author	Ociskova M Prasko J Kamaradova D Grambal A Kasalova P Sigmundova Z Latalova K Vrbova K
author_facet	Ociskova M Prasko J Kamaradova D Grambal A Kasalova P Sigmundova Z Latalova K Vrbova K
author_sort	Ociskova M
title	Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
title_short	Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
title_full	Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
title_fullStr	Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
title_full_unstemmed	Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
title_sort	coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders
publisher	Dove Medical Press
publishDate	2015
url	https://doaj.org/article/1c9076f8df884d93a82979148a293db7
work_keys_str_mv	AT ociskovam copingstrategieshopeandtreatmentefficacyinpharmacoresistantinpatientswithneuroticspectrumdisorders AT praskoj copingstrategieshopeandtreatmentefficacyinpharmacoresistantinpatientswithneuroticspectrumdisorders AT kamaradovad copingstrategieshopeandtreatmentefficacyinpharmacoresistantinpatientswithneuroticspectrumdisorders AT grambala copingstrategieshopeandtreatmentefficacyinpharmacoresistantinpatientswithneuroticspectrumdisorders AT kasalovap copingstrategieshopeandtreatmentefficacyinpharmacoresistantinpatientswithneuroticspectrumdisorders AT sigmundovaz copingstrategieshopeandtreatmentefficacyinpharmacoresistantinpatientswithneuroticspectrumdisorders AT latalovak copingstrategieshopeandtreatmentefficacyinpharmacoresistantinpatientswithneuroticspectrumdisorders AT vrbovak copingstrategieshopeandtreatmentefficacyinpharmacoresistantinpatientswithneuroticspectrumdisorders
_version_	1718400396863471616

Coping strategies, hope, and treatment efficacy in pharmacoresistant inpatients with neurotic spectrum disorders

Ejemplares similares